Group One Trading
GENE

Group One Trading’s Genetic Technologies Ltd. GENE Stock Holding History

Group One Trading’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$484 – 8185
2023
Q4 		$484 Buy
200
+160
+400% +$531 ﹤0.01% 7095
2023
Q3 		$154 Sell
40
-20
-33% -$82 ﹤0.01% 7445
2023
Q2 		$251 Buy
+60
New +$297 ﹤0.01% 7451
2023
Q1 		– Sell
-8,180
Closed -$37.2K – 8140
2022
Q4 		$37.2K Sell
8,180
-10,000
-55% -$56.7K ﹤0.01% 5208
2022
Q3 		$108K Buy
18,180
+9,900
+120% +$72.2K ﹤0.01% 4711
2022
Q2 		$47K Sell
8,280
-19,860
-71% -$144K ﹤0.01% 5623
2022
Q1 		$277K Sell
28,140
-7,720
-22% -$75K ﹤0.01% 4453
2021
Q4 		$337K Buy
35,860
+24,180
+207% +$310K ﹤0.01% 4556
2021
Q3 		$180K Sell
11,680
-280
-2% -$4.8K ﹤0.01% 5288
2021
Q2 		$254K Buy
11,960
+9,400
+367% +$190K ﹤0.01% 4969
2021
Q1 		$53K Buy
2,560
+2,360
+1,180% +$54K ﹤0.01% 6183
2020
Q4 		$4K Buy
+200
New +$3.3K ﹤0.01% 6125
2013
Q4 		– Sell
-127
Closed -$29K – 5614
2013
Q3 		$29K Buy
+127
New +$30.2K ﹤0.01% 3944

Other funds holding GENE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading's GENE Position: Q1 2022 in Review

Group One Trading sold out of Genetic Technologies Ltd. (GENE) in Q1 2022, closing a stake of 2,242 shares — an estimated $21.8K sold.

Group One Trading first reported a position in GENE in Q2 2013 and held it in 10 quarters. The position peaked at $338K in Q2 2021. 12 funds tracked by Wall St. Rank hold GENE as of Q1 2022.

  • Group One Trading reported no remaining Genetic Technologies Ltd. position as of Q1 2022 after selling out during the quarter.
  • Group One Trading sold 2,242 Genetic Technologies Ltd. shares in Q1 2022, an estimated $21.8K.
  • Group One Trading first reported a position in Genetic Technologies Ltd. in Q2 2013 and held it in 10 quarters.
  • Group One Trading's Genetic Technologies Ltd. position peaked at $338K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.